Home/Filings/4/0000882104-16-000250
4//SEC Filing

PDL BIOPHARMA, INC. 4

Accession 0000882104-16-000250

CIK 0000882104operating

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:17 PM ET

Size

4.5 KB

Accession

0000882104-16-000250

Insider Transaction Report

Form 4
Period: 2016-12-13
Hart Danny J Jr.
Assoc Genl Counsel/Asst Sec
Transactions
  • Disposition to Issuer

    Common stock

    2016-12-131,844188,217 total

Issuer

PDL BIOPHARMA, INC.

CIK 0000882104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000882104

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:17 PM ET
Size
4.5 KB